🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this observational study is to learn whether routine stool test...
Status
Recruiting
Location
Faculty of Medicine Cairo University
Start Date
2026-04-05
Trial ID
NCT07461610
Treatments Being Tested
According to inclusion and exclusion criteria, 20 eligible subjects with tr...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2025-03-01
Trial ID
NCT07046455
Treatments Being Tested
The purpose of this study is to conduct a pilot randomized controlled trial...
Status
Terminated
Location
Grady Health System (non-CRN)
Start Date
2010-05-13
Trial ID
NCT03463980
Treatments Being Tested
The objectives of this study are to assess the initial safety and device fu...
Status
Completed
Location
Clínica Colonial Hospital
Start Date
2023-12-12
Trial ID
NCT06200896
Treatments Being Tested
This is a Phase 1b/2, Open-label Study to Investigate the Safety and Effica...
Status
Recruiting
Location
USC Norris Comprehensive Cancer Center
Start Date
2025-03-24
Trial ID
NCT06827613
Treatments Being Tested
The purpose of this study is to evaluate salivary gland and labial mucous m...
Status
Completed
Location
UNIFESP
Start Date
2008-12
Trial ID
NCT01178242
Treatments Being Tested
This prospective study aimed to determine the alcohol intake symptoms and a...
Status
Completed
Location
University of Rome "la sapienza"
Start Date
2018-01-01
Trial ID
NCT04079023
Treatments Being Tested
Clinical Outcomes and Safety of Sacituzumab Govitecan in Metastatic HER-2 n...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2024-08-12
Trial ID
NCT06966141
To evaluate the effect and explore the mechanism of action behind the poten...
Status
Unknown
Location
Annelies Geeraerts
Start Date
2021-01-29
Trial ID
NCT05094895
Refining neoadjuvant chemoimmunotherapy and establishing predictive biomark...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-15
Trial ID
NCT07271992
Treatments Being Tested